SUBSCRIBE
SUBSCRIBE

Genentech, Inc.

NEWS
Business
Employee Taken to Hospital After Genentech Hazmat Spill in South San Francisco
July 14, 2016
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Policy
Genentech, OSI Pharma to Fork Over $67 Million for Misleading Info About Cancer Drug Efficacy
June 7, 2016
 · 
2 min read
ASCO2016: Immunomedics Breast Cancer Abstract Booted from Conference
Drug Development
ASCO2016: Genentech’s TECENTRIQ Shrank Tumors in People with Previously Untreated Advanced Bladder Cancer
June 6, 2016
 · 
3 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Genentech’s Gazyva Meets Primary Endpoint Early in Late-Stage Study
May 27, 2016
 · 
3 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Biotech Bay
Nine Bay Area Biotechs Vie to be the “Next Genentech”
May 24, 2016
 · 
4 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
FDA
Genentech Nabs FDA Approval of First New Bladder Cancer Drug in 30 Years
May 18, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Biotech Bay
Genentech May Owe Refunds to Some Healthcare Providers Over 340B Price Violations
May 12, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Astex Pharma and Genentech Forge a Clinical Trial Deal for Acute Myeloid Leukemia
April 20, 2016
 · 
3 min read
Happy 40th Birthday, Genentech!
Job Trends
Happy 40th Birthday, Genentech
April 8, 2016
 · 
2 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
Policy
Genentech Release: FDA Grants Priority Review For Venetoclax New Drug Application
January 12, 2016
 · 
6 min read
Drug Development
Genentech Touts Hematology Data for Gazyva and Venetoclax in CLL
December 16, 2015
 · 
3 min read
FDA
Genentech Wins Accelerated Approval for Alecensa to Treat Specific Lung Cancer Patients
December 11, 2015
 · 
10 min read
Drug Development
Genentech Release: Pivotal Phase II Study Showed Nearly 80 Percent Of People With Hard-To-Treat Type Of Chronic Lymphocytic Leukemia Responded To Investigational Medicine Venetoclax
December 7, 2015
 · 
7 min read
Drug Development
Genentech Release: New Results From CLL11 Study Show Gazyva Provided People With Previously Untreated Chronic Lymphocytic Leukemia A Treatment-Free Period Of Nearly Four Years
December 7, 2015
 · 
1 min read
Biotech Bay
Genentech Release: Updated Data Showed Cotellic In Combination With Zelboraf Helped People With A Specific Type Of Advanced Melanoma Live Significantly Longer Than With Zelboraf Alone
November 23, 2015
 · 
15 min read
Business
California Life Sciences Association Adds Leaders From Genentech, Sanford Burnham Prebys Medical Discovery Institute And OncoCyte Corporation To Board Of Directors
November 23, 2015
 · 
5 min read
Business
Ophthotech Corporation Announces That Genentech, A Roche Wholly-Owned Subsidiary, Elects To Exercise Its Right To Opt-In To The Novartis Portion Of The Ophthotech / Novartis AG Ex-US Agreement For Fovista® To Treat Wet Age-Related Macular Degeneration
November 17, 2015
 · 
1 min read
Business
Genentech Partners Up with Novartis AG on Ex-U.S. Rights to Wet AMD Candidate Fovista
November 17, 2015
 · 
7 min read
FDA
FDA Green Lights Genentech’s Vemurafenib/Cobimetinib Combo for Melanoma
November 10, 2015
 · 
4 min read
Load More